Days Inventory is also known as Days Sales of Inventory (DSI). Evoke Pharma's Average Total Inventories for the
three
months ended in Dec. 2023 was €0.46 Mil. Evoke Pharma's Cost of Goods Sold for the
three
months ended in Dec. 2023 was €0.05 Mil.
Hence, Evoke Pharma's Days Inventory for the
three
months ended in Dec. 2023 was 773.09.
The historical rank and industry rank for Evoke Pharma's Days Inventory or its related term are showing as below:
STU:EV00'
s Days Inventory Range Over the Past 10 Years
Min: 233.66 Med: 465.69 Max: 990.11
Current: 782.66
During the past 13 years, Evoke Pharma's highest Days Inventory was 990.11. The lowest was 233.66. And the median was 465.69.
STU:EV00's Days Inventory is ranked worse than 96.81% of 972
companies
in the Drug Manufacturers industry
Industry Median: 158.805
vs STU:EV00: 782.66
Evoke Pharma's Days Inventory
increased
from Dec. 2022 (126.17) to Dec. 2023 (773.09).
It might indicate that Evoke Pharma's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Evoke Pharma's Inventory Turnover for the
three
months ended in Dec. 2023 was 0.12.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Evoke Pharma's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 0.30.
Evoke Pharma Days Inventory Historical Data
The historical data trend for Evoke Pharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Evoke Pharma's Days Inventory
For the Drug Manufacturers - Specialty & Generic subindustry, Evoke Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evoke Pharma's Days Inventory Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Evoke Pharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where Evoke Pharma's Days Inventory falls into.
Evoke Pharma Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Evoke Pharma's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evoke Pharma (STU:EV00) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Evoke Pharma's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Evoke Pharma's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Evoke Pharma Days Inventory Related Terms
Thank you for viewing the detailed overview of Evoke Pharma's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:EV00 has been successfully added to your 